Log In Sign Up

Trading

Trading

Browse Companies

Data

Data

Private Market Index

IPO Stock Tracker

Solutions

Solutions

For Institutions

For Shareholders

Insights

Insights

Popular Topics

Buying Pre-IPO Shares

Selling Pre-IPO Shares

Private Market Reports

Private Market Data & Analytics

About

About

Investor Relations

People & Culture

American Gene Technologies International Stock

americangene.comHealthcareFounded: 2007Funding to Date: $72.88MM

American Gene Technologies ("AGT") is an emerging gene and cell therapeutics company with a proprietary lentiviral platform capable of broad applications including large and orphan indications, infectious disease, immune-oncology, and monogenic disorders.

Buy or sell American Gene Technologies International stock Learn more about American Gene Technologies International IPO

Overview Financings Valuation

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for American Gene Technologies International.

Register Today

Team

Management Team

David Pauza Ph.D

Chief Science Officer

Norman Rogers

Executive, Business Development

Jeffrey Galvin

Co-Founder, Chief Executive Officer & Board Member

Neil Lyons

Chief Financial Officer & Executive Vice President

Board Members

Julia Brown

Qi Tang

Jeffrey Galvin

Aaron Galvin

Tommy Thompson JD

Other companies like American Gene Technologies International in the Healthcare sector

Sector

Last Round Est. Valuation

$3.67B

Sector

Last Round Est. Valuation

$809.52MM

Colossal Biosciences

Sector

Last Round Est. Valuation

$1.01B

Sector

Sector

Last Round Est. Valuation

$4.26B

Sector

Sector

Last Round Est. Valuation

$396.01MM

Sector

Last Round Est. Valuation

$400.53MM

Sector

Last Round Est. Valuation

$1.53B

Frequently Asked Questions

Updated on: Jun 5, 2023